The current study demonstrates two functions of CM: firstly, it enhanced the response rate to immunosuppressant PD-L1 inhibitor, which led to a synergistic effect and enhanced the effect of PD-L1 inhibitor on the tumor; secondly, CM improved the diet and activity of mice with a large tumor load, which further improved their quality of life. This evidence concerns the gene CD274 and neoplasm.